Moneycontrol PRO
Black Friday Sale
Black Friday Sale
HomeNewsTrendsHealthBlack Fungus | Over 11,000 Mucormycosis cases in India; Gujarat, Maharashtra worst affected

Black Fungus | Over 11,000 Mucormycosis cases in India; Gujarat, Maharashtra worst affected

While Gujarat has logged 2,859 Black Fungus cases so far, Maharashtra has reported 2,770 cases, followed by 768 Mucormycosis cases in Andhra Pradesh, 752 in Madhya Pradesh, and 744 in Telangana. Together, these five states account for more than 65 percent of India’s total Black Fungus caseload.

May 26, 2021 / 17:05 IST
A graphic representation of the black fungus affecting COVID-19 patients (Image: News18 Creative)

India has registered 11,717 cases of Black Fungus infection or Mucormycosis till May 25, with maximum cases being reported from Gujarat, followed by Maharashtra.

While Gujarat has logged 2,859 Black Fungus cases so far, Maharashtra has reported 2,770 cases, followed by 768 Mucormycosis cases in Andhra Pradesh, 752 in Madhya Pradesh, and 744 in Telangana. Together, these five states account for more than 65 percent of India’s total Black Fungus caseload.

According to Delhi Chief Minister Arvind Kejriwal, the National Capital has reported 620 Black Fungus cases so far. But Union Minister Sadananda Gowda said on May 26 that there have been 119 Mucormycosis cases in Delhi.

Mucormycosis, though not new to India, was not as rampant as it is at present. Health experts believe that the over-use of steroids, coupled with low immunity, and immune suppression following COVID-19 recovery has made people more vulnerable to contracting the Black Fungus infection.

In view of the rapid increase in the number of Black Fungus cases being reported, 11 states across the country have so far declared it a notifiable disease under the Epidemic Disease Act, including Telangana, Rajasthan, Bihar, West Bengal, and Karnataka.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Sharing data on Black Fungus disease on Twitter on May 26, Union Minister Sadananda Gowda said 29,250 additional vials of the Amphotericin B drug being used to treat Mucormycosis have been distributed between all states and UTs, depending on the number of cases reported by each.

While 7,210 vials of Amphotericin B have been allocated to Gujarat, 6,980 were given to Maharashtra, 1930 to Andhra Pradesh, 1,910 to Madhya Pradesh, and 1,890 to Telangana.

Moneycontrol News
first published: May 26, 2021 05:05 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347